Opinion: On World Cancer Day, what’s wrong with a bit of Neuroendocrine Cancer awareness?

Translate
Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 14.2K other subscribers
Blog Stats
  • 2,251,246 hits

On World Cancer Day, what’s wrong with a bit of Neuroendocrine Cancer awareness?  Well, there are three main things wrong with Neuroendocrine Cancer awareness:

 

If the community does not address these 3 issues, awareness will continue to fail and continue to flounder.  I standby to help with the change, in fact, my work started in 2015 and continues. 

1.  To be told your cancer isn’t really cancer is an insult.

2.  To be called an animal is to be dehumanised.  

3.  To be rare when you’re not, is a step back and is hindering access to clinical trial research. 

WE NEED A NEW PARADIGM. 

 
 

First thing wrong

The community remains entrenched in 1907 terminology which needs to be brought into 2021. Things have moved on so much but the use of this ancient terminology and what it infers, just keeps us marking time in the last century. It does not do us any favours in awareness terms, nor does it do us any favours in clinical terms.  If clinicians, scientific organsiations (including pharma), and patient advocate organisations will not move on, we as patients and advocates need to pull them along with us.   We need to do all we can to remove the term “Carcinoid” from our vocabulary.   Read more on this issue by clicking here or on the picture:

Second thing wrong

When an outsider looks into the Neuroendocrine Cancer community, it shouldn’t be a surprise if their first thoughts were that it was some sort of animal welfare or zoological group, particularly focused on black and white striped animals.  Unfortunately, on this issue, the community seems to be so infatuated by the subject, that it’s blinkered to the abject failure of this marketing gimmick and it’s more of a cult than a community.  Like the 1907 parlance above, we also need to move away from this cult thing.  Maybe we should employ marketeers in our international awareness activities and if we currently do, then we need another set ASAP.  Read more here or click on the picture:

Third thing wrong

Finally, and I guess this is related to both of the issues above, more with the animal stuff than the nomenclature issue, the incidence and prevalence of Neuroendocrine Neoplasms (the combination of Neuroendocrine Tumours (NET) and Neuroendocrine Carcinomas (NEC)) have skyrocketed in the last 40 years to the point that many scientists, epidemiologists and Neuroendocrine specialists are starting to use different terminology, commensurate with the math.  Read more by clicking here or on the picture below.  Let’s do the math not the myth.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 14.2K other subscribers

Thanks for reading.

Ronny

Personal Facebook. Like this page please.
Blog Facebook. Like this page please.
Awareness Facebook Like this page please.

Sign up for my newsletters – Click Here

Disclaimer

My Diagnosis and Treatment History

Follow me on twitter

Check out my online presentations

Check out my WEGO Health Awards

Check out my Glossary of Terms – click here

patients included

Please Share this post for Neuroendocrine Cancer awareness and to help another patient

 
 
 
Facebook
Twitter
Pinterest
WhatsApp
Email

Neuroendocrine Cancer: Question, Clarify, Confirm

One of the many observations I make in my private Neuroendocrine Cancer Facebook group is the misunderstandings caused by the use of non-standard terminology combined

Read More »

Clinical Trial – Lutathera NETTER-2 Important Update

UPDATE – Sep 25th, 2023 – Novartis radioligand therapy Lutathera® demonstrated statistically significant and clinically meaningful progression-free survival in first line advanced gastroenteropancreatic neuroendocrine tumors

Read More »
Lanreotide: Ipsen injection devices vs generic injection devices

Lanreotide: Ipsen injection devices vs generic injection devices

Whenever I get a chance to talk to a pharma involved in somatostatin analogue injection devices, I tell them one very important thing …… “To

Read More »

Cancer doesn’t take holidays (but I do)

Glen Etive Scotland in 2018 After diagnosis in July 2010, with the exception of a planned holiday to Turkey prior to my ‘big surgery’, holidays

Read More »

Update from Ronny Allan: No evidence of progressive disease at any site

Update August 2023. Latest CT surveillance scan reports “No evidence of progressive disease at any site”. Very pleased! With incurable but treatable cancers such as

Read More »

Exercise is Medicine

Exercise is medicine.  Clearly I need to be careful with that statement given my aversion for cancer myths.  However, those who know me will totally

Read More »

Jimmy Buffett 1946-2023 – Neuroendocrine Carcinoma (Merkel Cell Carcinoma)

US singer-songwriter Jimmy Buffett, best known for his 1970’s hit Margaritaville, has died aged 76. “Jimmy passed away peacefully on the night of September 1

Read More »

Passive patient or active advocate?

I’ve been researching Neuroendocrine Cancer for some time now.  Why do I do this?  Whilst I have a great medical team, I’d also like to

Read More »

Childhood Cancer Awareness Month – Neuroendocrine Cancer (featuring Elizabeth)

September is Childhood Cancer Awareness Month!  The newspapers and social media will no doubt be featuring many childhood cancer articles. You may not see one

Read More »

2 thoughts on “Opinion: On World Cancer Day, what’s wrong with a bit of Neuroendocrine Cancer awareness?

  • I am in total agreement. Terminology must change so patients with NETs understand this disease is not rare. NETs is not as common as some other cancers and can be tricky to diagnose. Of course, there is a process of elimination through various tests and procedures. But thinking in terminology taught in medical schools must change.

    My husband, a practicing radiologist until his death last month, lived by the zebra code. OLD SCHOOL! We must use proper language to describe common, not so common and uncommon medical conditions. Patients need to educated, not insulted.

I love comments - feel free!

%d bloggers like this:
Verified by MonsterInsights